Action plans to reduce hospitalizations for chronic obstructive pulmonary disease exacerbations: Focus on oral corticosteroids

Current Medical Research and Opinion

Volumn 30, Issue 12, 2014, Pages 2607-2615

  Self, Timothy H ^a   Patterson, Shanise J ^a   Headley, Arthur S ^a   Finch, Christopher K ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

COPD exacerbations; Hospitalizations; Self management action plans

Indexed keywords

GLUCOCORTICOID;

COMPLICATION; DISEASE MANAGEMENT; HOSPITALIZATION; HUMAN; ORAL DRUG ADMINISTRATION; PATIENT CARE PLANNING; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SELF CARE;

ADMINISTRATION, ORAL; DISEASE MANAGEMENT; GLUCOCORTICOIDS; HOSPITALIZATION; HUMANS; PATIENT CARE PLANNING; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SELF CARE;

EID: 84914163583     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2014.934795     Document Type: Article

References (35)

1. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2014. Global Initiative for Chronic Obstructive Lung Disease. Available at: www.goldcopd.org [Last accessed 21 February 2014]
2. American Lung Association. Available at: www.lung.org/lung-disease/ [Last accessed 21 February 2014]
3. Guarascio AJ, Ray SM, Finch CK, et al. The clinical and economic burden of chronic obstructive pulmonary disease in the USA. ClinicoEconomics Outcomes Research 2013;5:235-45
4. Garcia-Aymerich J, Pons IS, Mannino DM, et al. Lung function impairment COPD hospitalizations and subsequent mortality. Thorax 2011;66:585-90
5. Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbations in chronic obstructive pulmonary disease. N Engl J Med 2010;363:1128-38
6. Centers for Medicare and Medicaid Services. Readmissions Reduction Program. Available at: http://www.cms.gov/Medicare/Medicare-Fee-for- Service-Payment/AcuteInpatientPPS/Readmissions-Reduction-Program.html [Last accessed 27 November 2013]
7. Niewoehner DE, Erbland ML, Deupree RH, et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. N Engl J Med 1999;340:1941-7
8. Davies L, Angus RM, Calverley PMA. Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomized trial. Lancet 1999;354:456-60
9. Albert RK, Martin TR, Lewis SW. Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency. Ann Intern Med 1980;92:753-8
10. Murata GH, Gorby MS, Chick TW, et al. Intravenous and oral corticosteroids for the prevention and relapse after treatment of decompensated COPD: effect of patients with a history of multiple relapses. Chest 1990;98:845-9
11. Aaron SD, Vandemheen KL, Hebert P, et al. Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease. N Engl J Med 2003;348:2618-25
12. Thompson WH, Nielson CP, Carvalho P, et al. Controlled trial of oral prednisone in outpatients with acute COPD exacerbation. Am J Respir Crit Care Med 1996;154:407-12
13. Leuppi JD, Schuetz P, Bingisser R, et al. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: The REDUCE randomized clinical trial. JAMA 2013;309:2223-31
14. Bourbeau J, Julien M, Maltais F, et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease. Arch Intern Med 2003;163:585-91
15. Sridhar M, Taylor R, Dawson S, et al. A nurse led intermediate care package in patients who have been hospitalized with an acute exacerbation of chronic obstructive pulmonary disease. Thorax 2008;63:194-200
16. Effing T, Kerstjens H, van der Valk P, et al. Cost-effectiveness of self-treatment of exacerbations on the severity of exacerbations in patients with COPD: the COPE II study. Thorax 2009;64:956-62
17. Rice KL, Dewan N, Bloomfield HE, et al. Disease management program for chronic obstructive pulmonary disease: a randomized controlled trial. Am J Respir Crit Care Med 2010;182:890-6
18. Fan VS, Gaziano JM, Lew R, et al. A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations. Ann Intern Med 2012;156:673-83
19. Rabe KF, Hurd S, Anzueto A, et al; Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176:532-55
20. Seemungal TA, Donaldson GC, Bhowmik A, et al. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;161:1608-13
21. Wilkinson TMA, Donaldson GC, Hurst JR, et al. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;169:1298-303
22. Beaulieu-Genest L, Chretien D, Maltais F, et al. Self-administered prescriptions of oral steroids and antibiotics in chronic obstructive pulmonary disease: are we doing more harm than good? Chron Respir Dis 2007;4:143-7
23. Sedeno MF, Nault D, Hamd DH, et al. A self-management education program including an action plan for acute COPD exacerbation. COPD 2009;6:352-8
24. Bischoff EWMA, Hamd DH, Sedeno M, et al. Effects of written action plan adherence on COPD exacerbation recovery. Thorax 2011;66:26-31
25. Guell R, Casan P, Belda J, et al. Long-term effects of outpatient rehabilitation of COPD: a randomized trial. Chest 2000;117:976-83
26. Watson PB, Town GI, Holbrook N, et al. Evaluation of a self-management plan for chronic obstructive pulmonary disease. Eur Respir J 1997;10:1267-71
27. Monninkhof E, van der Valk P, vander Palen J, et al. Effects of a comprehensive self-management programme in patients with chronic obstructive pulmonary disease. Eur Respir J 2003;22:815-20
28. Self TH, Chrisman CR, Jacobs AR, et al. Preventing emergency department visits and hospitalizations for asthma by use of oral corticosteroids at home: are we adhering to national guidelines? J Asthma 2010;47:1123-7
29. Expert Panel Report 3. Guidelines for the Diagnosis and Management of Asthma. National Asthma Education and Prevention Program. Bethesda, MD: National Institutes of Health, 2007
30. Pocock SJ. Ethical dilemmas and malfunctions in clinical trials research. Ann Intern Med 2012;156:746-7
31. Yeatts KB, Lippmann SJ, Waller AE, et al. Population-based burden of COPDrelated visits in the ED: return ED visits, hospital admissions, and comorbidity risks. Chest 2013;144:784-93
32. Miravitlles M, Moragas A, Hernandez S, et al. Is it possible to identify exacerbations of mild to moderate COPD that do not require antibiotic treatment. Chest 2013;144:1571-7
33. Garcia-Rio F, Rojo B, Casitas R, et al. Prognostic value of the objective measurement of daily physical activity in patients with COPD. Chest 2012;142:338-46
34. Zanoria SJ, ZuWallack R. Directly measured physical activity as a predictor of hospitalizations in patients with chronic obstructive pulmonary disease. Chron Respir Dis 2013;10:207-13
35. Andrews J, Sathe NA, Krishnaswami S, et al. Nonpharmacologic airway clearance techniques in hospitalized patients: a systematic review. Respir Care 2013;58:2160-86